$0.10
(7.81%)
Create an alert
Stocks and Shares ISAAIxCrypto Holdings, Inc., formerly Qualigen Therapeutics, Inc., is focused on building an ecosystem that integrates Artificial Intelligence (AI) and blockchain, bridging Web2 and Web3. This ecosystem unites a decentralized protocol, distributed network, AI DePIN and EAI RWA value regeneration, and a DeAI Agent product and technology platform designed to achieve optimal trading performance. Its core products include the BesTrade DeAI Agent and the AIxC ecosystem products. Its crypto business, CXC10, is centered on three growth engines which include six key products: C - Crypto 10 (C10) as Value Anchor, X - DeAI Agent, and C - RWA & Ecosystem Tokens. C - Crypto 10 (C10) as Value Anchor - through the C10 Digital Asset Treasury, C10 Index, and a potential C10 ETF. C - RWA & Ecosystem Tokens - including the C10 Stablecoin and the EAI + Crypto Dual-Bridge Real World Asset product, bridging traditional assets with Web3. It also develops and commercializes oncology and immunology therapies.
Company Information
About this company
Key people
Jay Sheng
Chairman of the Board
Campbell Becher
President
Kevin Richardson
Co-Chief Executive Officer, Director
Jiawei Wang
Co-Chief Executive Officer
Koti Meka
Chief Financial Officer, Executive Director
Chad Chen
Director
Kevin Chen
Independent Director
Click to see more
Key facts
- Shares in issue20.23m
- EPICAIXC
- ISINUS74754R3012
- LocationUnited States
- SectorTechnology
- IndustryComputer Services
- Market cap$25.09m
- Employees10
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.